Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | SPR | P35270 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24676040 | 0.91 | TRPV1 (0.34) | TRPV1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL24676509 | 0.91 | TRPV1 (0.34) | TRPV1PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25164697 | 0.76 | TRPV1 (0.41) | TRPV1HCRTR2PSEN1PSEN2APH1B | |
| SCHEMBL29754965 | 0.76 | TRPV1 (0.37) | TRPV1HCRTR2PSEN1PSEN2APH1B | |
| SCHEMBL24676720 | 0.75 | — | — | |
| SCHEMBL24676986 | 0.74 | CHRM2 (0.33) | — | |
| SCHEMBL29754833 | 0.73 | — | — | |
| SCHEMBL24676724 | 0.73 | OGA (0.34) | TRPV1 | |
| SCHEMBL29754880 | 0.73 | TRPV1 (0.43) | TRPV1HCRTR2PSEN1PSEN2APH1B | |
| SCHEMBL29754886 | 0.73 | TRPV1 (0.43) | TRPV1HCRTR2PSEN1PSEN2APH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |